Clearance of a thick invasive squamous cell carcinoma after multiple treatments with topical photodynamic therapy.

OBJECTIVE Tumor depth is the limiting factor for topical photodynamic therapy (PDT) treating cutaneous invasive squamous cell carcinoma (SCC). The thickness of  < 2-3 mm below the epidermis is the currently recommended effective response depth in nonmelanoma skin cancers. We report an unusual outgrowing SCC with a tumor depth of 5.5 mm, which was successfully treated with PDT. METHODS Topical 20% (wt/wt) 5-aminolaevulinic acid emulsion was applied for 6 h before irradiation with 633-nm red light. The lesion was irradiated 7 times, 1 week apart, at a total dose of 791 J/cm(2). RESULTS Twelve months later, histologic and clinical examination showed a complete remission and no local or systemic metastases. No serious side effects occurred, and the cosmetic outcome was excellent. CONCLUSION PDT may offer a noninvasive, well-tolerated, and effective therapy for inoperable low-risk SCC with an outgrowing pattern. It suggests that tumor depth is not an absolute predictor, but only a suggested reference.

[1]  Y. Tamada,et al.  Photodynamic therapy following carbon dioxide laser enhances efficacy in the treatment of extramammary Paget's disease. , 2009, Acta dermato-venereologica.

[2]  C. Morton,et al.  Guidelines for topical photodynamic therapy: update , 2008, The British journal of dermatology.

[3]  G. Parrinello,et al.  Methylaminolaevulinate‐based photodynamic therapy of Bowen’s disease and squamous cell carcinoma , 2008, The British journal of dermatology.

[4]  E. Alexandratou,et al.  Topical photodynamic therapy of murine non‐melanoma skin carcinomas with aluminum phthalocyanine chloride and a diode laser: pharmacokinetics, tumor response and cosmetic outcomes , 2008, Photodermatology, photoimmunology & photomedicine.

[5]  M. Landthaler,et al.  Variable pulsed light is less painful than light-emitting diodes for topical photodynamic therapy of actinic keratosis: a prospective randomized controlled trial. , 2007, The British journal of dermatology.

[6]  I. Tan,et al.  Photodynamic therapy in the treatment of multiple primary tumours in the head and neck, located to the oral cavity and oropharynx , 2007, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.

[7]  A. Ackerman,et al.  Nomenclature for Very Superficial Squamous Cell Carcinoma of the Skin and of the Cervix: A Critique in Historical Perspective , 2006, The American Journal of dermatopathology.

[8]  D. Cassarino,et al.  Cutaneous squamous cell carcinoma: a comprehensive clinicopathologic classification , 2006, Journal of cutaneous pathology.

[9]  D. Cassarino,et al.  Cutaneous squamous cell carcinoma: a comprehensive clinicopathologic classification , 2006 .

[10]  D. Selva,et al.  Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia I. Experience over 10 years. , 2005, Journal of the American Academy of Dermatology.

[11]  Todd T. Kobayashi,et al.  Nevoid basal cell carcinoma syndrome or multiple hereditary infundibulocystic basal cell carcinoma syndrome? , 2004, Journal of the American Academy of Dermatology.

[12]  Petras Juzenas,et al.  Effectiveness of different light sources for 5-aminolevulinic acid photodynamic therapy , 2004, Lasers in Medical Science.

[13]  Mitchel P Goldman,et al.  5‐Aminolevulinic Acid Photodynamic Therapy: Where We Have Been and Where We Are Going , 2004, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[14]  K. Mckenna,et al.  Evaluation of the penetration of 5‐aminolevulinic acid through basal cell carcinoma: a pilot study , 2004, Experimental dermatology.

[15]  M. Bulsara,et al.  Cold Air Analgesia in Photodynamic Therapy of Basal Cell Carcinomas and Bowen's Disease: An Effective Addition to Treatment A Pilot Study , 2004, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[16]  A. Kubin,et al.  Cold-knife conization versus photodynamic therapy with topical 5-aminolevulinic acid (5-ALA) in cervical intraepithelial neoplasia (CIN) II with associated human papillomavirus infection: a comparison of preliminary results. , 2003, Anticancer research.

[17]  W. Xu,et al.  Evaluation of photodynamic therapy of skin cancers with δ-aminolevulinic acid , 2002 .

[18]  R. M. Szeimiesa,et al.  Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study. , 2002 .

[19]  H Moseley,et al.  Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group , 2002, The British journal of dermatology.

[20]  S B Bird,et al.  Clinically significant changes in pain along the visual analog scale. , 2001, Annals of emergency medicine.

[21]  M. Ala-opas,et al.  Effect of photodynamic therapy on urinary bladder function: an experimental study with rats , 2001, Urological Research.

[22]  T. Stephenson,et al.  Photodynamic therapy for dysplastic Barrett's oesophagus: a prospective, double blind, randomised, placebo controlled trial , 2000, Gut.

[23]  Ninomiya,et al.  Photodynamic therapy for inoperable vulval Paget's disease using δ‐aminolaevulinic acid: successful management of a large skin lesion , 1999, The British journal of dermatology.

[24]  T. Humphreys,et al.  Treatment of superficial basal cell carcinoma and squamous cell carcinoma in situ with a high-energy pulsed carbon dioxide laser. , 1998, Archives of dermatology.

[25]  H. Soyer,et al.  Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical delta-aminolevulinic acid photodynamic therapy. , 1998, Archives of dermatology.

[26]  J H McColl,et al.  Photodynamic therapy for basal cell carcinoma: effect of tumor thickness and duration of photosensitizer application on response. , 1998, Archives of dermatology.

[27]  Š. Spaventi,et al.  INTERFERON REDUCES RECURRENCES OF BASAL CELL AND SQUAMOUS CELL CANCERS , 1995, International journal of dermatology.

[28]  A A Gage,et al.  The five-year cure rate achieved by cryosurgery for skin cancer. , 1991, Journal of the American Academy of Dermatology.

[29]  Jean-Jacques Grob,et al.  Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial. , 2004, Archives of dermatology.

[30]  D. Salomon,et al.  Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study. , 2002, Journal of the American Academy of Dermatology.

[31]  W. Xu,et al.  Evaluation of photodynamic therapy of skin cancers with partial differential alpha-aminolevulinic acid. , 2002, Chinese medical journal.

[32]  H Kerl,et al.  Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. An alternative treatment modality for solar keratoses, superficial squamous cell carcinomas, and basal cell carcinomas? , 1993, Journal of the American Academy of Dermatology.

[33]  R. F. Ryan,et al.  Topical use of 5-fluorouracil cream for skin cancer. , 1971, Modern trends in surgery.